Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03289546 · ClinicalTrials.gov registry record · NA

The Active Mind Study

A NA study, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT03289546: Completed NA study, sponsored by The Miriam Hospital.

NCT03289546 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03289546, a NA study, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

The purpose of this study is to explore whether physical exercise, mindfulness training, or both interventions together can improve cognitive function in individuals with multiple risk factors for the development of dementia in the future.

Primary Outcome

The investigators will consider the study feasible under this condition

Interventions

  • BEHAVIORAL Mindfulness training
  • BEHAVIORAL Aerobic training

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2016-04-01
Est. Completion 2018-12-31
Phase NA
The Miriam Hospital

136 total trials

What the finished NCT03289546 record still lists

NCT03289546 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Mindfulness training is the first listed.

NCT03289546 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03289546 about?

NCT03289546 is a clinical study titled "The Active Mind Study". The purpose of this study is to explore whether physical exercise, mindfulness training, or both interventions together can improve cognitive function in individuals with multiple risk factors for the development of dementia in the future.

What is the current status of trial NCT03289546?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2016-04-01. Estimated completion is 2018-12-31.

What interventions are being tested in trial NCT03289546?

The interventions under investigation include: Mindfulness training (BEHAVIORAL), Aerobic training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03289546?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03289546's enrollment target sits among peer trials

38 1538th of 2000 higher than 461 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03289546, the US trial registry maintained by the National Library of Medicine. NCT03289546 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.